Literature DB >> 16682816

Dose-dependent UV stabilization of p53 in cultured human cells undergoing apoptosis is mediated by poly(ADP-ribosyl)ation.

Jungyeon Won1, So Young Chung, Seung Beom Kim, Boo Hyeong Byun, Yoo Sik Yoon, Cheol O Joe.   

Abstract

The effect of poly(ADP-ribosyl)ation on the stability of p53 in SK-HEP1 cells treated with UV light was examined. Intracellular levels of p53 increased in cells treated with a low dose of UV light (20 J/m2), whereas they increased but then declined after a higher dose of UV (100 J/m2). Intracellular levels of p53 in the UV treated SK-HEP1 cells were dependent on the UV dose. Use of proteasome inhibitors revealed that p53 is degraded by proteasomal proteolysis after high doses of UV light. We present evidence that, at low doses, poly(ADP-ribose)polymerase (PARP) poly(ADP-ribosyl)ates p53 and protects it from proteasomal degradation before caspase-3 is activated, whereas at high doses the cells undergo UV induced apoptosis and PARP is cleaved by caspase-3 before it can protect p53 from degradation. Destabilization of p53 by cleavage of PARP may be important in cell fate decision favoring apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682816

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  3 in total

1.  PARP-1: a new player in the asthma field?

Authors:  É Szabó; I Kovács; T Grune; A Haczku; L Virág
Journal:  Allergy       Date:  2011-02-02       Impact factor: 13.146

2.  Poly(ADP-ribosyl)ation of p53 contributes to TPEN-induced neuronal apoptosis.

Authors:  Hyun-Lim Kim; Hana Ra; Ki-Ryeong Kim; Jeong-Min Lee; Hana Im; Yang-Hee Kim
Journal:  Mol Cells       Date:  2015-03-20       Impact factor: 5.034

3.  Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.

Authors:  Akiko Okuda; Suguru Kurokawa; Masanori Takehashi; Aika Maeda; Katsuya Fukuda; Yukari Kubo; Hyuma Nogusa; Tomoka Takatani-Nakase; Shujiro Okuda; Kunihiro Ueda; Seigo Tanaka
Journal:  BMC Neurosci       Date:  2017-01-17       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.